Accretive Health (AH) Misses Q2 EPS by 5c; Slashes FY12 EPS Outlook

August 8, 2012 7:47 AM EDT Send to a Friend
Accretive Health (NYSE: AH) reported Q2 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $236.7 million versus the consensus estimate of $234.64 million.

Sees FY2012 EPS of $0.23-$0.27, versus prior guidance of $0.42-$0.50 and the consensus of $0.41.

For earnings history and earnings-related data on Accretive Health (AH) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings

Add Your Comment